Viewing Study NCT06149494


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-02 @ 1:46 AM
Study NCT ID: NCT06149494
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2023-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Sponsor: Altesa Biosciences, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COPD Exacerbation Acute View
None COPD With Acute Lower Respiratory Infection View
None Rhinovirus View
None Virus Diseases View
None Virus Infection, RNA View
None Enterovirus View
None Enterovirus Infections View
None Rhinovirus Infection View
None Infection Viral View
None Respiratory Complication View
None Respiratory Disease View
None Respiratory Tract Infections View
None Respiratory Tract Diseases View
None Respiratory Viral Infection View
None Upper Resp Tract Infection View
None Upper Respiratory Tract Infections View
None Upper Respiratory Disease View
None Upper Respiratory Disorder View
None Upper Respiratory Disease, Acute View
None Upper Respiratory Infection Viral View
None Infections, Respiratory View
None Infections View
None Copd View
None Viral Infection View
None Emphysema or COPD View
None Lower Respiratory Disease View
None Lower Respiratory Disorder View
None Lower Respiratory Tract and Lung Infections View
None Pulmonary Disease View
None Pulmonary Disease, Chronic Obstructive View
None Respiratory Disease Chronic View
None Lung Diseases View
None Lung Disease Chronic View
None Obstructive Pulmonary Disease View
None Chronic Lower Respiratory Diseases View
None Chronic Respiratory Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Randomized View
None Double-blind View
None Phase 2 View
None Placebo-Controlled View
None Clinical study View
None Clinical trial View
None Randomization View
None Interventional View